- Investor's Business Daily•5 hours ago
Amgen will likely beat Eli Lilly, Alder and Teva to market with an antibody-blocking migraine med.
- 24/7 Wall St.•5 hours ago
September 29, 2016: Here are four stocks trading with relatively heavy volume among 42 equities making new 52-week lows in Thursday’s session. NYSE decliners led advancers by 3 to 1 and Nasdaq decliners ...
- Business Wire•5 hours ago
Teva Pharmaceutical Industries Ltd. today announced the launch of a generic equivalent of Epzicom®1 tablets, 600 mg/300 mg, in the United States .
Teva Pharmaceutical Industries Limited (TEVA)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||46.37 x 100|
|Ask||46.40 x 200|
|Day's Range||46.08 - 48.88|
|52wk Range||46.08 - 66.55|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||30.92|
|Avg Vol (3m)||5,825,100|
|Dividend & Yield||1.36 (2.75%)|